Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / AIDS / October 2005

Tip: Looking for answers? Try searching our database.

Dr. Rasnick's letter to Business Day

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
David Canzi -- non-mailable - 14 Oct 2005 03:46 GMT
http://www.dr-rath-health-foundation.org.za/rasnick_aug05.htm

| The authors state that, "Without trial evidence, this
| information must come from observational cohort studies. However,
| estimation of treatment effects in observational studies is not
| straightforward..." Indeed it is not, yet that is exactly what
| the authors did by using a "novel methodology to overcome this
| problem".
|
| To generate the results that so heartened TAC, the authors had
| to resort to a statistical method that they acknowledge "is not
| widely used in clinical research" and in fact "may not be widely
| known in the clinical research community". Yet, their results
| are not obtainable without this unused and unknown methodology.

The authors ofthe Lancet article Dr. Rasnick is criticizing used a
relatively new statistical method, "marginal structural models", to
better extract the signal of causation from the noise of confounding
factors in the observational data.

Any statistical method is mathematical by nature.  This method will
be based on assumptions about the effects a causal realationship and
confounding factors will have on the observational data, and justiified
by mathematical arguments.  There is no sign that Dr. Rasnick has
examined the assumptions and arguments supporting the new method.
Therefore, when he criticizes the new method as "unused and unknown",
he is criticizing the new method not for any known flaws, but for
the fact that he doesn't understand it.

Signature

David Canzi            "I am not denying anything." -- Celia Farber

Chris Noble - 14 Oct 2005 04:30 GMT
Where are the control groups in Rasnick's "scientific trial" of Rath's
pills?

Why isn't Rasnick's study placebo double blind controlled?

There is not one single placebo double blind controlled study of Rath's
AIDS cure. Does this stop him from announcing this in full color
advertisements and press releases?

Rath announced his findings in a press release before the work was
published or even submitted to peer-review. Actually it was before the
study was approved by any medical authority in SA.

Anyway, how dare somebody use mathematics in a scientific paper. The
only scientific way is to use anecdotes complete with before and after
photographs and testimonials.

Chris Noble
Fondoo - 14 Oct 2005 05:21 GMT
Why isn't Rasnick's study placebo double blind controlled?

Come on Chris if you don't need placebo blind controlled studies to show
the effectiveness of giving cancer drugs and PI's to AIDS patients why
start now?
  Orthodox studies are riddled with this trouble or am I wrong?
Chris Noble - 14 Oct 2005 05:39 GMT
> Why isn't Rasnick's study placebo double blind controlled?
>
>  Come on Chris if you don't need placebo blind controlled studies to show
> the effectiveness of giving cancer drugs and PI's to AIDS patients why
> start now?
>    Orthodox studies are riddled with this trouble or am I wrong?

You mean it's OK for Rasnick and other dissidents to complain that
trials of HAART are not placebo double blind controlled (the trials
compare different drug combinations with earlier treatments) and then
conduct poorly controlled and unapproved "trials" and then announce
through press releases and paid advertisements that they have the cure
for AIDS?

Does the word hypocrite mean anything to you?

I also question Rasnicks statistical methods. It has come to light that
some of Rasnick's successes were using ARVs at the time. More
importantly some of the people taking Rath's pills died. What sort of
statistical treatment did Rasnick use to cover up these cases of "lost
to follow-up"?

http://www.mg.co.za/articlePage.aspx?articleid=253582&area=/breaking_news/breaki
ng_news__national/

http://allafrica.com/stories/200510130169.html

Chris Noble
Fondoo - 14 Oct 2005 06:16 GMT
  Chris I don't know this guys work at all, I just seen a pot calling the
kettle black.
  Mostly I am angry at our own government failure to protect us from
big-pharma's agenda.
  We should be looking like crazy at the people that refuse AIDS drugs
and live healthy long lives and not promoting them as these rare cases or
calling everything they die of AIDS related without solid evidence.
  My wife and I were both told we had AIDS over 10 years ago, my wife had
3 T-Cells! There are a great many stories like this and will be a great
many more as news gets around in the underground that the media and
research is heavily biased.
  More and more people are going to think twice about there doctors
orders and find that they are inappropriate for there bodies. I think
there is solid evidence that AIDS drugs have helped people with some OI’s
but the evidence and giving drugs to healthy people based only on T-Cells
and a positive test is very questionable. Suppressing the questions and
not providing studies to answer them is wrong
Chris Noble - 14 Oct 2005 06:33 GMT
> Chris I don't know this guys work at all, I just seen a pot calling the
> kettle black.

The pot is Rasnick. He is the one who has been insisting on the
importance of double blind placebo controlled trials.

But does he follow his own advice?

Apparently there is one standard for orthodox science and another for
Rasnick.

Why do you leap to his defence?

Chris Noble
Fondoo - 14 Oct 2005 07:28 GMT
 I'm not defending Rasnick but the lack of double blinds in AIDS research
is a pet peeve of mine and it came to mind.
 Hell anyone that says they can cure AIDS with a product they want to
sell goes right on my "kook for profit" list because I believe different
people get AIDS for different reasons so one cure for all cases seems very
far fetched.
 Hell even if it is HIV I think we could turn it into a non issue by
supporting holistic living and treatment of the bodies infected.
 The problem is that’s EXACTLY what drug companies do not want to
encourage for ANYONE. Maybe if CODEX is successful in getting vitamins
regulated and therapeutic doses become very costly and profitable they
will allow the studies and AIDS will dry up
Chris Noble - 14 Oct 2005 07:35 GMT
> I'm not defending Rasnick but the lack of double blinds in AIDS research
> is a pet peeve of mine and it came to mind.

Which trial of ARVs is not double blind?

Do you know any?

Chris Noble
Fondoo - 14 Oct 2005 08:05 GMT
Which trial of ARVs is not double blind?

Do you know any?

Chris Noble

 Sorry double blind "placebo" controlled
You know the kind that would help us determine between drug toxicity and
HIV/AIDS damage

Chris Noble - 14 Oct 2005 08:11 GMT
> Which trial of ARVs is not double blind?
>
[quoted text clipped - 5 lines]
> You know the kind that would help us determine between drug toxicity and
> HIV/AIDS damage

What would you predict for double blind trials comparing combinations
of 2 ARVs and 3 ARVs?

Which group would you expect to remain healthier longer?

What would that tell you about drug toxixity and the effects of HIV?

Would you ignore any of these studies?

Chris Noble
pauleewhiting - 14 Oct 2005 11:50 GMT
"What would you predict for double blind trials comparing combinations of 2
ARVs and 3 ARVs?

Which group would you expect to remain healthier longer?

What would that tell you about drug toxixity and the effects of HIV?

Would you ignore any of these studies?"

Chris,

How does comparing different ARVs to each other establish whether the ARVs
are better than no treatment at all?

That would be like comparing apples to oranges by studying *only*
different kinds of apples!

How many long-term, double-blind PLACEBO controlled studies have been done
on the effectiveness of ARVs over no treatment at all?

Remember, after you provided me with the link for that *one* study, I
asked you if that was the study which the approval of AZT was based upon?

Remember, I asked you if that was the *only* double-blind placebo control
ever done?

How many have there been?

-Paul
GMCarter - 14 Oct 2005 13:13 GMT
snip
>How does comparing different ARVs to each other establish whether the ARVs
>are better than no treatment at all?

It doesn't. But that kind of study would be deemed unethical because
we have a lot of clinical data that show that ARV use dramatically
reduces morbidity and mortality.

This is rooted in earlier placebo-controlled studies.

So to suggest a placebo-controlled study would be
a) not accepted by MOST HIV+ in the community;
b) therefore would not enroll;
c) would not be sponsored by the NIH or hospitals or universities as
their Institutional Review Boards would deem it unethical.

Who would enroll in such a study?

If you're a denialist, you won't WANT to risk getting the drugs. If
you think ARV is going to help, you wouldn't WANT to risk placebo.

Do you ever think?

        George M. Carter
DavidT - 14 Oct 2005 14:07 GMT
Imagine you have a new drug for treating leukaemia. You have to compare
this to the best available current therapy for 2 reasons -
1. It is unethical to give half the leukaemia patients nothing
(placebo)
2. You want to know if it is better OR WORSE than current best therapy
- if it fares no better, it will not be developed/used.

So what do you do with a "new" antiretroviral?
Not what Rasnick/Rath suggest anyway...
DavidT - 14 Oct 2005 14:13 GMT
Paulee, you know full well that denialists claim the drugs cause AIDS.

So why do those on 2 drugs do better than those on one/none, those on 3
do better than those on 2, and those on 4 do better than those on 3?
Why does gigaHAART (6+ drugs) do better than nothing in patients with
resistant virus?

Perhaps for once you could answer those specific points, rather than
change subject
copi - 14 Oct 2005 14:49 GMT
>So why do those on 2 drugs do better than those on one/none, those on 3
>do better than those on 2, and those on 4 do better than those on 3?
>Why does gigaHAART (6+ drugs) do better than nothing in patients with
>resistant virus?

because ARVs may work on possible latent spirochetes.
Dr. Rasnick treated acute infection in rabbits very well
with protease inhibitors:

http://aidsmyth.addr.com/news/000529syphilisdebate.htm
GMCarter - 14 Oct 2005 15:22 GMT
>>So why do those on 2 drugs do better than those on one/none, those on 3
>>do better than those on 2, and those on 4 do better than those on 3?
[quoted text clipped - 6 lines]
>
>http://aidsmyth.addr.com/news/000529syphilisdebate.htm

What protease inhibitors? Inhibiting what protease?

Syphilis is undoubtedly an important concomitant. Effective
treatmentis critical and may be inadequate in the U.S. But it just
does NOT look the same as HIV infection. The only comment on that page
that is remotely intriguing is:

" Half a century later, Dr. Sandra Larsen, the CDC's chief syphilis
expert for many years, made a curious observation in an abstract
presented at an STD meeting in 1991: "The clinical manifestations of
syphilis, which have taken various forms over the centuries, have now
been transformed to mimic the appearance of the opportunistic
infections and cancers that may accompany HIV infection, as well as
the clinical symptoms of AIDS itself.""

I would like to see any evidence that in HIV-negative individuals,
syphilis infection results in relevant clinical sequelae as seen in
AIDS and/or a decline in CD4 count.

        George M. Carter
copi - 14 Oct 2005 16:06 GMT
>I would like to see any evidence that in HIV-negative individuals,
>syphilis infection results in relevant clinical sequelae as seen in
>AIDS and/or a decline in CD4 count.
>
>              George M. Carter

why this? HIV tests and spirochete antigens are not necessary
independent.
HIV obviously tracks the process of late stage syphilis, occuring after

undetected multiple reinfections.

other hiv-tests maybe tracking other cohorts.
mainly drug user (p24) , because the CDC wanted them in 1983
to be tracked (sharing needle theory)
GMCarter - 14 Oct 2005 16:55 GMT
>>I would like to see any evidence that in HIV-negative individuals,
>>syphilis infection results in relevant clinical sequelae as seen in
[quoted text clipped - 4 lines]
>why this? HIV tests and spirochete antigens are not necessary
>independent.

You're claiming syphilis causes CD4+ depletion?

>HIV obviously tracks the process of late stage syphilis, occuring after
>undetected multiple reinfections.

Does it? Based on what?

>other hiv-tests maybe tracking other cohorts.
>mainly drug user (p24) , because the CDC wanted them in 1983
>to be tracked (sharing needle theory)

What the hell are you dithering about now? Syphilis...let's see, it
expresses p24? It's passed by sharing syringes?

Please do enlighten! Can't wait to see what you're on about now.

        George M. Carter
copi - 14 Oct 2005 17:36 GMT
> >>I would like to see any evidence that in HIV-negative individuals,
> >>syphilis infection results in relevant clinical sequelae as seen in
[quoted text clipped - 6 lines]
>
> You're claiming syphilis causes CD4+ depletion?

wrong question at this point.
you wanted:

>I would like to see any evidence that in HIV-negative individuals,
>syphilis infection ...

this only makes sense, if HIV and syphilis are INDEPENDENT.
its your turn, to prove that.

sorry, Georgiboy
GMCarter - 14 Oct 2005 18:04 GMT
>> >>I would like to see any evidence that in HIV-negative individuals,
>> >>syphilis infection results in relevant clinical sequelae as seen in
[quoted text clipped - 8 lines]
>
>wrong question at this point.

No, it ain't.

>you wanted:

Who the f.ck are you to tell me what I want?

>>I would like to see any evidence that in HIV-negative individuals,
>>syphilis infection ...
[quoted text clipped - 3 lines]
>
>sorry, Georgiboy

LOL. You claim now that everybody with syphilis is HIV+?????

My turn to prove nothing, copribreath.

        George M. Carter
copi - 15 Oct 2005 19:07 GMT
>LOL. You claim now that everybody with syphilis is HIV+?????

of course, HIV-ccr5 positive
GMCarter - 15 Oct 2005 22:33 GMT
>>LOL. You claim now that everybody with syphilis is HIV+?????
>
>of course, HIV-ccr5 positive

So everyone with CCR5 has HIV??

Wow. Fascinating.
copi - 17 Oct 2005 13:53 GMT
>>LOL. You claim now that everybody with syphilis is HIV+?????

>of course, HIV-ccr5 positive

>So everyone with CCR5 has HIV??

No. HIV does not exist.

hiv-ccr5 is just a code for ccr5only.
serious scientists dont want to be trolled from glaxo trolls.

http://aids-info.net/micha/hiv/aids/english.html
GMCarter - 17 Oct 2005 14:01 GMT
>>>LOL. You claim now that everybody with syphilis is HIV+?????
>
[quoted text clipped - 3 lines]
>
>No. HIV does not exist.

Yes. It does.

>hiv-ccr5 is just a code for ccr5only.

What?

>serious scientists dont want to be trolled from glaxo trolls.

Are you a serious scientist?

I have nothing to do with pharma except mostly as a vocal critic. I do
not get paid by Glaxo or any other pharmaceutical company.

Who pays you?

        George M. Carter
DavidT - 14 Oct 2005 17:56 GMT
>Dr. Rasnick treated acute infection in rabbits very well
>with protease inhibitors:
http://aidsmyth.addr.com/news/000529syphilisdebate.htm

I can see no reference to the relevant clinical trial.
Can you give us a reference for this please?
Gary Stein - 15 Oct 2005 00:32 GMT
> "What would you predict for double blind trials comparing combinations of
> 2
[quoted text clipped - 10 lines]
> How does comparing different ARVs to each other establish whether the ARVs
> are better than no treatment at all?

Well for you whack jobs that think ARV is so very deadly it would certainly
prove your point if it were true. However the data shows just the opposite
effect adding a third ARV medication to a 2 drug combo improves outcomes.
Now if you were right it should show that adding additional ARV medications
would cause the patients health to crash due to your so called idea about
the deadly nature of ARV.

Gary Stein
Fondoo - 15 Oct 2005 02:37 GMT
 I would discount all there value until we have explored how much less
ARV's can be used.
  If untreated control arms are unethical they should be done on a
volunteer basis.
 Personally I think the drug companies already now they are drastically
over prescribing and put profit before health. Just my .02
GMCarter - 15 Oct 2005 11:31 GMT
>  I would discount all there value until we have explored how much less
>ARV's can be used.

THAT's a possibility certainly for the nuke class. Lower doses of AZT
and d4T can be as effective and less toxic. Possibly so for ddI. 3TC
is relatively nontoxic.

>   If untreated control arms are unethical they should be done on a
>volunteer basis.

Then you wouldn't have a control arm and the results would be suspect.

>  Personally I think the drug companies already now they are drastically
>over prescribing and put profit before health. Just my .02

Yes, they are overpromoting and thus physicians may be
overprescribing based on patient requests and/or pharma "bribes." But
not necessarily with ARV. PHarma doesn't prescribed. Physicians do.

        George M. Carter
j.umber@ac-nancy-metz.fr - 15 Oct 2005 19:49 GMT
here in french a review of probable properties of 3TC

http://www.sidasante.com/azt/lamivudine_et_sida/lamivudine_et_sida.htm
Fondoo - 17 Oct 2005 12:05 GMT
Pharma pays for studies, Pharma high ranking executives can go to work for
the FDA and vice a versa FDA and congress are allowed to invest in pharma
if this situation leads to corrupt data our doctors can not help but to
over prescribe because protocol is based on study results this would go
way beyond over promoting.
 I am no scientist but an average guy being forced to play detective to
protect his family from some very scary protocols with very poor results,
pediatric AIDS being a true horror story in failure for a father. Having
my babies parents die from liver failure is another.
    Funny thing death from AIDS is barely a bleep on the radar. That
bleep is enough to hire a Chinese doc and test for oxidative stress mind
you. But I believe in instinct and mine says I am on the right path.
  My only real contribution is my story so I am exited to see how it
unfolds. Hell I was sure I would die of my drug use and or AIDS 10 years
ago this is all bonus time 
GMCarter - 17 Oct 2005 12:59 GMT
>Pharma pays for studies, Pharma high ranking executives can go to work for
>the FDA and vice a versa FDA and congress are allowed to invest in pharma
>if this situation leads to corrupt data our doctors can not help but to
>over prescribe because protocol is based on study results this would go
>way beyond over promoting.

Ah--not exactly. Pharma does pay for studies. So do we: via the NIH.
(FDA approves drugs or not.)

People that work for HHS don't get paid much. Conflicts of interest
rules apply ostensibly to prevent corruption. They kinda work but
there are lots of flaws and weaknesses (notably in enforcement).

These are real issues. And pharma has totally f.cked up and distorted
the value of science by turning clinical trials into little more than
marketing tools. It is disgusting.

Medicine should be a public venture. Not a private one as the private
sector has shown that it acts on the philosophy that profits trump
human life.

        George M. Carter
Gary Stein - 15 Oct 2005 00:28 GMT
>   Chris I don't know this guys work at all, I just seen a pot calling the
> kettle black.
[quoted text clipped - 3 lines]
> and live healthy long lives and not promoting them as these rare cases or
> calling everything they die of AIDS related without solid evidence.

What makes you think that is not being done?

Gary Stein
Fondoo - 14 Oct 2005 06:19 GMT
  I also would not give credit to anyone with a cure for AIDS. I think
AIDS has multiple causes so there can be no magic bullet. Just my .02
wilyretrovirus - 14 Oct 2005 15:15 GMT
Good points, Chris
GMCarter - 14 Oct 2005 12:38 GMT
>Why isn't Rasnick's study placebo double blind controlled?
>
> Come on Chris if you don't need placebo blind controlled studies to show
>the effectiveness of giving cancer drugs and PI's to AIDS patients why
>start now?
>   Orthodox studies are riddled with this trouble or am I wrong?

Yes. Most good clinical studies have a placebo. However, once a
"standard of care" develops, then it is considered unethical to
randomize people to nothing when there already exists a treatment.

There have been studies of multivitamins. Indeed, a recent one in
Tanzania showed that a multi can cut the rate of progression to AIDS
by 30%!! This is important. A follow up study, below, shows other
benefits.

I STRONGLY believe that a multi should be a standard of care for all
people with HIV the world over. It is an inexpensive and
effective--and very safe--intervention. It is criminal and despicable
that there are virtually no efforts in this regard.;

However, that being said, a.sholes like Rath totally piss me off. I
wish a multi WAS a cure--but it is NOT. It is an important treatment
intervention. But it doesn't stop AIDS. And for him to spew this
nonsense makes it easier for those particular asswipe doctors who
don't know their a.s from a hole in the ground to dismiss this
intervention (and others just follow along like bleating sheep).

Rath helps foster the false polemic that is anathema for those of us
living with chronic infections.

        George M. Carter

**
Villamor E, Saathoff E, Manji K, Msamanga G, Hunter DJ, Fawzi WW.
Vitamin supplements, socioeconomic status, and morbidity events as
predictors of wasting in HIV-infected women from Tanzania. Am J Clin
Nutr. 2005 Oct;82(4):857-65.

Departments of Nutrition and Community Health, Muhimbili University
College of Health Sciences, Dar es Salaam, Tanzania.

   BACKGROUND: Wasting is a strong independent predictor of mortality
in HIV-infected persons. Vitamin supplements delay the disease
progression, but their effect on wasting is not known. Data are
lacking on the risk factors for wasting in African HIV-infected
persons. OBJECTIVES: The objectives were to examine the effect of
vitamin supplements on wasting in HIV-infected women and to assess the
effects of sociodemographic characteristics, morbidity events, and
immunologic progression on the risk of wasting. DESIGN: HIV-infected
women (n = 1078) from Tanzania were randomly assigned to receive 1 of
4 daily oral regimens: multivitamins (B complex, C, and E), vitamin A
plus beta-carotene, multivitamins that included vitamin A plus
beta-carotene, or placebo. The endpoints of the study included first
episodes of a midupper arm circumference <22 cm or a body mass index
(BMI; in kg/m(2)) <18 and the incidence of weight loss episodes during
a median 5.3 y of follow-up. RESULTS: Multivitamins alone
significantly reduced the risk of a first episode of a midupper arm
circumference <22 cm (relative risk: 0.66; 95% CI: 0.47, 0.94; P =
0.02). In multivariate-adjusted Cox models, the woman's age, education
level, and height were inversely related to the incidence of wasting.
Episodes of diarrhea, nausea or vomiting, lower respiratory tract
infections, oral ulcers, thrush, severe anemia, and low CD4(+) cell
counts were each significantly related to an increased risk of
wasting. CONCLUSIONS: Vitamins C and E and the vitamin B complex have
a protective effect on wasting in HIV-infected women. Prevention of
diarrhea, severe respiratory tract infections, and anemia are likely
to decrease the burden of wasting.
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.